Cargando…
Intracameral dexamethasone reduces inflammation on the first postoperative day after cataract surgery in eyes with and without glaucoma
PURPOSE: To evaluate whether dexamethasone injected intracamerally at the conclusion of surgery can safely and effectively reduce postoperative inflammation and improve surgical outcomes in eyes with and without glaucoma. METHODS: Retrospective chart review of 176 consecutive eyes from 146 patients...
Autores principales: | Chang, Diane TW, Herceg, Michael C, Bilonick, Richard A, Camejo, Larissa, Schuman, Joel S, Noecker, Robert J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2708982/ https://www.ncbi.nlm.nih.gov/pubmed/19668589 |
Ejemplares similares
-
Comparative Outcomes of Standard Perioperative Eye Drops, Intravitreal Triamcinolone Acetonide-Moxifloxacin, and Intracameral Dexamethasone-Moxifloxacin-Ketorolac in Cataract Surgery
por: Kuriakose, Robin K., et al.
Publicado: (2022) -
Comparison of intracameral dexamethasone and intracameral triamcinolone acetonide injection at the end of phacoemulsification surgery
por: Güngör, Sirel Gür, et al.
Publicado: (2014) -
Comparison of intracameral dexamethasone and intracameral triamcinolone acetonide injection at the end of phacoemulsification surgery
por: Ozge, Gokhan, et al.
Publicado: (2015) -
Intracameral dexamethasone injection in the treatment of cataract surgery induced inflammation: design, development, and place in therapy
por: Shah, Tirth J, et al.
Publicado: (2018) -
Incidence of postoperative endophthalmitis with and without use of intracameral moxifloxacin
por: Porwal, Amit C, et al.
Publicado: (2021)